FDA Approval Rounded Out a Successful 2014 for Cancer Immunotherapy
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
As 2014 draws to a close, we look back on an exciting year during which we provided more than...
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause...
Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
According to a new report in Cancer Epidemiology, Biomarkers & Prevention, the levels of several toxic substances are elevated...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
A new study shows big data can be exploited to develop effective breast cancer prevention strategies and the NIH...